These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26188518)

  • 1. SH2 domain-containing inositol 5-phosphatase (SHIP2) regulates de-novo lipogenesis and secretion of apoB100 containing lipoproteins in HepG2 cells.
    Gorgani-Firuzjaee S; Khatami S; Adeli K; Meshkani R
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1028-1033. PubMed ID: 26188518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SH2 domain-containing inositol 5-phosphatase (SHIP2) inhibition ameliorates high glucose-induced de-novo lipogenesis and VLDL production through regulating AMPK/mTOR/SREBP1 pathway and ROS production in HepG2 cells.
    Gorgani-Firuzjaee S; Meshkani R
    Free Radic Biol Med; 2015 Dec; 89():679-89. PubMed ID: 26456051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins.
    Qiu W; Federico L; Naples M; Avramoglu RK; Meshkani R; Zhang J; Tsai J; Hussain M; Dai K; Iqbal J; Kontos CD; Horie Y; Suzuki A; Adeli K
    Hepatology; 2008 Dec; 48(6):1799-809. PubMed ID: 19026012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of SH2-domain-containing inositol 5-phosphatase (SHIP2) ameliorates palmitate induced-apoptosis through regulating Akt/FOXO1 pathway and ROS production in HepG2 cells.
    Gorgani-Firuzjaee S; Adeli K; Meshkani R
    Biochem Biophys Res Commun; 2015 Aug; 464(2):441-6. PubMed ID: 26123392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of transgenic overexpression of SH2-containing inositol 5'-phosphatase 2 on glucose metabolism and insulin signaling in mice.
    Kagawa S; Soeda Y; Ishihara H; Oya T; Sasahara M; Yaguchi S; Oshita R; Wada T; Tsuneki H; Sasaoka T
    Endocrinology; 2008 Feb; 149(2):642-50. PubMed ID: 18039790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
    Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
    Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
    Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
    Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
    Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5'-phosphatase 2) on insulin signaling and glucose metabolism in mice.
    Fukui K; Wada T; Kagawa S; Nagira K; Ikubo M; Ishihara H; Kobayashi M; Sasaoka T
    Diabetes; 2005 Jul; 54(7):1958-67. PubMed ID: 15983195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling.
    Ishihara H; Sasaoka T; Hori H; Wada T; Hirai H; Haruta T; Langlois WJ; Kobayashi M
    Biochem Biophys Res Commun; 1999 Jun; 260(1):265-72. PubMed ID: 10381377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oleate activates SREBP-1 signaling activity in
    Lounis MA; Bergeron KF; Burhans MS; Ntambi JM; Mounier C
    Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E710-E720. PubMed ID: 28851735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of prandial blood glucose and improvement of glucose tolerance by liver-specific inhibition of SH2 domain containing inositol phosphatase 2 (SHIP2) in diabetic KKAy mice: SHIP2 inhibition causes insulin-mimetic effects on glycogen metabolism, gluconeogenesis, and glycolysis.
    Grempler R; Zibrova D; Schoelch C; van Marle A; Rippmann JF; Redemann N
    Diabetes; 2007 Sep; 56(9):2235-41. PubMed ID: 17596404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
    Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
    Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
    Tsai J; Qiu W; Kohen-Avramoglu R; Adeli K
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):211-8. PubMed ID: 17038630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of SH2-domain containing inositol phosphatase 2 (SHIP2) in insulin producing INS1E cells improves insulin signal transduction and induces proliferation.
    Grempler R; Leicht S; Kischel I; Eickelmann P; Redemann N
    FEBS Lett; 2007 Dec; 581(30):5885-90. PubMed ID: 18061583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes.
    Sasaoka T; Hori H; Wada T; Ishiki M; Haruta T; Ishihara H; Kobayashi M
    Diabetologia; 2001 Oct; 44(10):1258-67. PubMed ID: 11692174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.
    Onnockx S; De Schutter J; Blockmans M; Xie J; Jacobs C; Vanderwinden JM; Erneux C; Pirson I
    J Cell Physiol; 2008 Jan; 214(1):260-72. PubMed ID: 17620296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AUP1 (Ancient Ubiquitous Protein 1) Is a Key Determinant of Hepatic Very-Low-Density Lipoprotein Assembly and Secretion.
    Zhang J; Zamani M; Thiele C; Taher J; Amir Alipour M; Yao Z; Adeli K
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):633-642. PubMed ID: 28183703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin.
    Blero D; De Smedt F; Pesesse X; Paternotte N; Moreau C; Payrastre B; Erneux C
    Biochem Biophys Res Commun; 2001 Apr; 282(3):839-43. PubMed ID: 11401540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.